These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21153346)

  • 1. Lessons from anti-TNF biologics: infliximab failure in a TRAPS family with the T50M mutation in TNFRSF1A.
    Nedjai B; Quillinan N; Coughlan RJ; Church L; McDermott MF; Hitman GA; Turner MD
    Adv Exp Med Biol; 2011; 691():409-19. PubMed ID: 21153346
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of sustained response to etanercept and refractoriness to anakinra in patients with T50M TNF-receptor-associated periodic syndrome.
    Quillinan N; Mannion G; Mohammad A; Coughlan R; Dickie LJ; McDermott MF; McGonagle D
    Ann Rheum Dis; 2011 Sep; 70(9):1692-3. PubMed ID: 21378401
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumour necrosis factor receptor-associated periodic syndrome caused by a rare mutation in the TNFRSF1A gene, and with excellent response to etanercept treatment.
    Cantarini L; Lucherini OM; Galeazzi M; Fanti F; Simonini G; Baldari CT; Laghi Pasini F; De Martino M; Cimaz R
    Clin Exp Rheumatol; 2009; 27(5):890-1. PubMed ID: 19917181
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment.
    Stojanov S; Dejaco C; Lohse P; Huss K; Duftner C; Belohradsky BH; Herold M; Schirmer M
    Ann Rheum Dis; 2008 Sep; 67(9):1292-8. PubMed ID: 18180277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor receptor-associated periodic syndrome as a cause of recurrent abdominal pain in identical twins and description of a novel mutation of the TNFRSF1A gene.
    Lee RU; Saland S; Sullivan S
    J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):e22-3. PubMed ID: 22343913
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor necrosis factor receptor-associated periodic fever syndrome in a 58-year-old man: caution not to discount TRAPS as a diagnosis in older patients.
    Sinožić D; Toplak N; Milotić I
    J Clin Rheumatol; 2011 Sep; 17(6):325-8. PubMed ID: 21869706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome.
    Nedjai B; Hitman GA; Quillinan N; Coughlan RJ; Church L; McDermott MF; Turner MD
    Arthritis Rheum; 2009 Feb; 60(2):619-25. PubMed ID: 19180495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives.
    Cantarini L; Lucherini OM; Muscari I; Frediani B; Galeazzi M; Brizi MG; Simonini G; Cimaz R
    Autoimmun Rev; 2012 Nov; 12(1):38-43. PubMed ID: 22884554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment with infliximab of a patient with tumor necrosis factor-associated periodic syndrome (TRAPS) who failed to respond to etanercept.
    Krelenbaum M; Chaiton A
    J Rheumatol; 2010 Aug; 37(8):1780-2. PubMed ID: 20675856
    [No Abstract]   [Full Text] [Related]  

  • 10. Delights and let-downs in the management of tumor necrosis factor receptor-associated periodic syndrome: the canakinumab experience in a patient with a high-penetrance T50M TNFRSF1A variant.
    Cantarini L; Lopalco G; Vitale A; Caso F; Lapadula G; Iannone F; Galeazzi M; Rigante D
    Int J Rheum Dis; 2015 May; 18(4):473-5. PubMed ID: 25522898
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature.
    Cantarini L; Rigante D; Lucherini OM; Cimaz R; Laghi Pasini F; Baldari CT; Benucci M; Simonini G; Di Sabatino V; Brizi MG; Galeazzi M
    Int J Immunopathol Pharmacol; 2010; 23(3):701-7. PubMed ID: 20943039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of a patient with tumor necrosis factor receptor-associated periodic syndrome using a half-dose of etanercept.
    Kusuhara K; Hoshina T; Saito M; Ishimura M; Inoue H; Horiuchi T; Sato T; Hara T
    Pediatr Int; 2012 Aug; 54(4):552-5. PubMed ID: 22830546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting TNF for Treatment of Cancer and Autoimmunity.
    Sethi G; Sung B; Kunnumakkara AB; Aggarwal BB
    Adv Exp Med Biol; 2009; 647():37-51. PubMed ID: 19760065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A.
    Nowlan ML; Drewe E; Bulsara H; Esposito N; Robins RA; Tighe PJ; Powell RJ; Todd I
    Rheumatology (Oxford); 2006 Jan; 45(1):31-7. PubMed ID: 16287931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal recessive transmission of TRAPS in a family with a novel TNFRSF1A mutation.
    Wong KK; Jackson J; Whidborne R; Mallon D; Bennetts B; D'Orsogna LJ
    Scand J Rheumatol; 2015 May; 44(3):255-6. PubMed ID: 25744939
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report.
    Catrina AI; Trollmo C; af Klint E; Engstrom M; Lampa J; Hermansson Y; Klareskog L; Ulfgren AK
    Arthritis Rheum; 2005 Jan; 52(1):61-72. PubMed ID: 15641091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor receptor 1-associated periodic syndrome without fever: cytokine profile before and during etanercept treatment.
    Morbach H; Richl P; Stojanov S; Lohse P; Girschick HJ
    Rheumatol Int; 2009 Dec; 30(2):207-12. PubMed ID: 19381634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder.
    Hull KM; Drewe E; Aksentijevich I; Singh HK; Wong K; McDermott EM; Dean J; Powell RJ; Kastner DL
    Medicine (Baltimore); 2002 Sep; 81(5):349-68. PubMed ID: 12352631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent abdominal pain as the presentation of tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in an Asian girl: a case report and review of the literature.
    Chen YJ; Yu HH; Yang YH; Lau YL; Lee WI; Chiang BL
    J Microbiol Immunol Infect; 2014 Dec; 47(6):550-4. PubMed ID: 22921805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the diagnosis and treatment of tumor necrosis factor receptor-associated periodic syndrome.
    Aguado-Gil L; Irarrazaval-Armendáriz I; Pretel-Irazabal M
    Actas Dermosifiliogr; 2013 Sep; 104(7):617-22. PubMed ID: 23891452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.